Annual Cash & Cash Equivalents
$435.45 M
+$313.82 M+258.02%
December 31, 2024
Summary
- As of March 15, 2025, DYN annual cash & cash equivalents is $435.45 million, with the most recent change of +$313.82 million (+258.02%) on December 31, 2024.
- During the last 3 years, DYN annual cash & cash equivalents has risen by +$234.62 million (+116.83%).
- DYN annual cash & cash equivalents is now at all-time high.
Performance
DYN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$435.45 M
-$96.71 M-18.17%
December 31, 2024
Summary
- As of March 15, 2025, DYN quarterly cash and cash equivalents is $435.45 million, with the most recent change of -$96.71 million (-18.17%) on December 31, 2024.
- Over the past year, DYN quarterly cash and cash equivalents has dropped by -$172.75 million (-28.40%).
- DYN quarterly cash and cash equivalents is now -28.40% below its all-time high of $608.20 million, reached on June 30, 2024.
Performance
DYN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DYN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +258.0% | -28.4% |
| 3 y3 years | +116.8% | +159.8% |
| 5 y5 years | +2876.0% | +159.8% |
DYN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +258.0% | -28.4% | +258.0% |
| 5 y | 5-year | at high | +2876.0% | -28.4% | +2876.0% |
| alltime | all time | at high | +5260.0% | -28.4% | +2876.0% |
Dyne Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $435.45 M(+258.0%) | $435.45 M(-18.2%) |
| Sep 2024 | - | $532.16 M(-12.5%) |
| Jun 2024 | - | $608.20 M(+123.6%) |
| Mar 2024 | - | $272.04 M(+123.7%) |
| Dec 2023 | $121.63 M(-29.3%) | $121.63 M(-6.6%) |
| Sep 2023 | - | $130.28 M(-22.3%) |
| Jun 2023 | - | $167.61 M(-7.5%) |
| Mar 2023 | - | $181.11 M(+5.2%) |
| Dec 2022 | $172.15 M | $172.15 M(+18.8%) |
| Sep 2022 | - | $144.90 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $135.98 M(-8.1%) |
| Mar 2022 | - | $147.97 M(-26.3%) |
| Dec 2021 | $200.82 M(-33.2%) | $200.82 M(-12.3%) |
| Sep 2021 | - | $229.04 M(-11.4%) |
| Jun 2021 | - | $258.38 M(-16.9%) |
| Mar 2021 | - | $310.95 M(+3.4%) |
| Dec 2020 | $300.85 M(+1956.1%) | $300.85 M(-20.7%) |
| Sep 2020 | - | $379.61 M(+162.0%) |
| Jun 2020 | - | $144.87 M(+890.1%) |
| Dec 2019 | $14.63 M(+80.1%) | $14.63 M |
| Dec 2018 | $8.12 M | - |
FAQ
- What is Dyne Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
- What is Dyne Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Dyne Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DYN is $435.45 M
What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash & cash equivalents is $435.45 M
What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DYN annual cash & cash equivalents has changed by +$313.82 M (+258.02%)
What is Dyne Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DYN is $435.45 M
What is the all time high quarterly cash and cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash and cash equivalents is $608.20 M
What is Dyne Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, DYN quarterly cash and cash equivalents has changed by -$172.75 M (-28.40%)